• Events
  • Media center
  • Careers
  • Contact
  • Support us
EORTC
  • Activities
    • Clinical trials
    • Other research initiatives
    • Data sharing
    • Quality assurance
    • Education & training
    • Early career
    • Public policy
  • Research fields
    • Tumours
    • Cross-discipline
  • Network & partners
    • Members
    • Partners
    • Government bodies
    • Liaison offices
  • Research tools
    • Tools
    • Clinical trials database
    • Bibliography
    • Policies
    • Guidelines
    • Request for data
  • About us
    • Our mission
    • Strategic overview
    • Funding
    • History
    • Governance
    • Headquarters
News : Jan Bogaerts, Methodology Vice Director at EORTC HQ, discusses clinical trial design for rare cancers with Helen Saul
EORTC trial evaluates androgen deprivation therapy for patients with recurrent / metastatic androgen receptor expressing salivary gland cancer
Back to news list
Saskia Litière, Biostatistician at the EORTC, discusses the ongoing evaluation of RECIST with Helen Saul
News Videos
Share
  • Linkedin
  • Twitter
  • Facebook

Jan Bogaerts, Methodology Vice Director at EORTC HQ, discusses clinical trial design for rare cancers with Helen Saul

10 Feb 2015

Hear Jan Bogaerts (photo), EORTC Methodology Vice Director, discuss “Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative”, an article published in European Journal of Cancer (2015) 51, 271-281.

EORTC trial evaluates androgen deprivation therapy for patients with recurrent / metastatic androgen receptor expressing salivary gland cancer
Back to news list
Saskia Litière, Biostatistician at the EORTC, discusses the ongoing evaluation of RECIST with Helen Saul

Related News

Does radiofrequency ablation of unresectable colorectal liver metastases prolong long-term survival?

23 Mar 2017

Could an early PET scan help better manage Hodgkin Lymphoma?

17 Mar 2017

EORTC introduces new quality of life module to measure cancer-related fatigue

7 Mar 2017

Does radiofrequency ablation of unresectable colorectal liver metastases prolong long-term survival?

23 Mar 2017

Could an early PET scan help better manage Hodgkin Lymphoma?

17 Mar 2017

RECIST working group issues modified guideline for immunotherapy

2 Mar 2017
  • Activities
    • Clinical trials
    • Other research initiatives
    • Data sharing
    • Quality assurance
    • Education & training
    • Early career
    • Public policy
  • Research fields
    • Tumours
    • Cross-discipline
  • Network & partners
    • Members
    • Partners
    • Government bodies
    • Liaison offices
  • Research tools
    • Tools
    • Clinical trials database
    • Bibliography
    • Policies
    • Guidelines
    • Request for data
  • About us
    • Our mission
    • Strategic overview
    • Funding
    • History
    • Governance
    • Headquarters
Subscribe to our newsletter Member area Eur. J. Cancer
Follow us on
  • Linkedin
  • Twitter
  • Facebook
  • Youtube
  • © EORTC
  • Legal notice
  • Cookies
  • link